Léa Hoisnard
Impact in
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
- Spondyloarthritis Studies and Treatments
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
-
- Meningioma and schwannoma management 5
- Cytomegalovirus and herpesvirus research 1
- Pneumocystis jirovecii pneumonia detection and treatment 1
-
- Biosimilars and Bioanalytical Methods 4
- Co-authors
- É. Sbidian (11 shared papers)Mahmoud Zureik (11 shared papers)Alain Weill (7 shared papers)Laura Pina Vegas (2 shared papers)Rosemary Dray‐Spira (2 shared papers)Lise Duranteau (5 shared papers)Sebastien C. Froelich (4 shared papers)Pascal Claudepierre (2 shared papers)
- Journals
- RMD Open (2 papers)Transplant International (2 papers)European Journal of Neurology (2 papers)Scientific Reports (2 papers)World Journal of Pediatrics (1 paper)
- Partner nations
- FranceUnited StatesCzechia
In The Last Decade
Léa Hoisnard
19 papers receiving 425 citations
Léa Hoisnard's Hit Papers
Peers
Comparison fields: 5 of 49
- Rheumatology 128
- Toxicology 25
- Transplantation 10
- Geriatrics and Gerontology 10
- Dermatology 22
Countries citing papers authored by Léa Hoisnard
This map shows the geographic impact of Léa Hoisnard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Léa Hoisnard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Léa Hoisnard more than expected).
Fields of papers citing papers by Léa Hoisnard
This network shows the impact of papers produced by Léa Hoisnard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Léa Hoisnard. The network helps show where Léa Hoisnard may publish in the future.
Co-authors
The 25 scholars most cited alongside Léa Hoisnard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database Hit paper breakdown → | 2022 | 131 |
| 2 | 2022 | 96 | |
| 3 | 2022 | 44 | |
| 4 | 2024 | 44 | |
| 5 | 2024 | 19 | |
| 6 | 2022 | 15 | |
| 7 | 2024 | 14 | |
| 8 | 2022 | 11 | |
| 9 | 2024 | 10 | |
| 10 | 2018 | 9 | |
| 11 | 2022 | 9 | |
| 12 | 2024 | 8 | |
| 13 | 2024 | 7 | |
| 14 | 2023 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2024 | 4 | |
| 17 | 2024 | 2 | |
| 18 | 2021 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 0 |
About Léa Hoisnard
Léa Hoisnard is a scholar working on Epidemiology, Immunology, Transplantation, Rheumatology and Geriatrics and Gerontology, having authored 20 papers that have together received 434 indexed citations. Recurring topics across this work include Meningioma and schwannoma management (5 papers), Biosimilars and Bioanalytical Methods (4 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Renal Transplantation Outcomes and Treatments (2 papers), Dermatology and Skin Diseases (1 paper), Cytomegalovirus and herpesvirus research (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and Renal Diseases and Glomerulopathies (1 paper). The work is most often cited by research in Rheumatology (128 citations), Toxicology (25 citations), Transplantation (10 citations), Geriatrics and Gerontology (10 citations) and Dermatology (22 citations). Léa Hoisnard has collaborated with scholars based in France, United States and Czechia. Frequent co-authors include É. Sbidian, Mahmoud Zureik, Alain Weill, Laura Pina Vegas, Rosemary Dray‐Spira, Lise Duranteau, Sebastien C. Froelich, Pascal Claudepierre, Philippe Grimbert and Aurélien Amiot. Their work appears in journals such as RMD Open, Transplant International, European Journal of Neurology, Scientific Reports and World Journal of Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.